TrialDiabetes, obesity & metabolism2020

Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial.

Tina Vilsbøll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.